Repository

• Home
• Repository
• Publications

Publications

Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential Gonzalez-Sanchez E, Roldan-Hernandez CA, Martin-Ramirez A, Garcia-Collado L, Fouassier L, Vaquero J Int J Mol Sci. 2025 Nov 18;26(22):11135. doi: 10.3390/ijms262211135 2025  Result from

Artificial Intelligence-based agents in chronic liver disease: transforming diagnostic and therapeutic workflows through clinical decision-making Singh Y, Hathaway QA, Vera-Garcia DV, Povero D, Salehi S, Wei Y, Horvat N, Chaudhary A, Mula Kh A, Keishing V, Niazi K, Quaia E, Erickson BJ, Gores GJ, Andersen JB npj Gut Liver 2, 34 (2025). https://doi.org/10.1038/s44355-025-00049-5 2025  Result from   Results from

Cholangiocarcinoma 2026: status quo, unmet needs and priorities Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S, Lleo A, Luedde T, Macias RIR, Morement H, Nault JC, Olaizola P, Perugorria MJ, Raggi C, Rimassa L, Saborowski A, Valle JW, Vithayathil M, Vogel A, Braconi C; International CCA Consensus Consortium. Nat Rev Gastroenterol Hepatol. 2026 Jan;23(1):65-96. doi: 10.1038/s41575-025-01153-w 2026  Result from

Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review Macarulla T, Neuzillet C, Prager GW, Rimassa L, Bridgewater J Oncol Ther. 2025 Dec;13(4):939-962. doi: 10.1007/s40487-025-00370-2 2025  Result from

Critical dialogue: Can AI-based imaging predict tumor biology? Infer metastasis, microvascular invasion, and growth patterns from pixels Singh Y, Gores GJ, Andersen JB, Salehi S, Erickson BJ. Insights Imaging. 2025 Nov 10;16(1):250. doi: 10.1186/s13244-025-02136-w 2025  Results from